On March 19th, the federal government loosened regulations around methadone and buprenorphine, two medications used to treat opioid addiction. The change was triggered by the novel coronavirus and concerns that current practices would either contribute to its spread or restrict critical opioid addiction treatment. For all the havoc the coronavirus is undoubtedly causing, it is also compelling us to examine our approach to these medications with a ...

Read more...

1 Pages

Most Popular

✓ Join 150,000+ subscribers
✓ Get KevinMD's most popular stories